| Treasury Manager |
Moscow (City) |
Russische Foed. |
Finance |
CTS |
Audit und Finanzen |
20. Juni 2024 |
| R2R Accountant |
Moscow (City) |
Russische Foed. |
Finance |
CTS |
Audit und Finanzen |
22. Oktober 2024 |
| Revenue Accounting Manager |
Shanghai (Shanghai) |
China |
Finance |
CTS |
Audit und Finanzen |
17. Juli 2024 |
| Associate Director ERC Risk&Operations, Corporate Functions |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compliance |
29. August 2024 |
| Head DPDAI China |
Shanghai (Shanghai) |
China |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compliance |
14. Oktober 2024 |
| Manager- Data Privacy Review and Remediation |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compliance |
14. Oktober 2024 |
| Risk & Assurance Manager |
Mumbai (Head Office) |
Indien |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compliance |
16. Oktober 2024 |
| Country ERC Head, India |
Mumbai (Office) |
Indien |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compliance |
16. Oktober 2024 |
| Ethics, Risk & Compliance Manager |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compliance |
22. August 2024 |
| Sr Manager/Manager-Monitoring |
Shanghai (Shanghai) |
China |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compliance |
18. Juli 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
09. Oktober 2024 |
| Research & Development Quality Specialist |
Barcelona Gran Vía |
Spanien |
Development |
Innovative Medicines |
Quality |
15. Oktober 2024 |
| SSO Finance Specialist |
İstanbul Kavacık |
Türkei |
Development |
Innovative Medicines |
Research & Development |
10. September 2024 |
| RA Manager, Procedural Documents |
London (The Westworks) |
Vereinigtes Königreich |
Development |
Innovative Medicines |
Research & Development |
10. September 2024 |
| RA GDD Project Specialist |
London (The Westworks) |
Vereinigtes Königreich |
Development |
Innovative Medicines |
Einrichtungen und Verwaltung |
10. September 2024 |
| Director, Global Operational Excellence |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
11. September 2024 |
| Senior Regulatory Affairs Manager |
Vietnam |
Vietnam |
Development |
Innovative Medicines |
Research & Development |
22. Oktober 2024 |
| Head, Clinical Development Strategy & Integration Lead |
Basel (City) |
Schweiz |
Development |
Innovative Medicines |
Research & Development |
12. September 2024 |
| Manager, Reg&Dev Policy Japan |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
12. September 2024 |
| Associate Director- Clinical Data Standards |
Mumbai (Office) |
Indien |
Development |
Innovative Medicines |
Research & Development |
13. September 2024 |
| Senior Global Risk Management Plan Manager |
Barcelona Gran Vía |
Spanien |
Development |
Innovative Medicines |
Research & Development |
16. September 2024 |
| Principal Biostatistician |
Home Worker |
Vereinigtes Königreich |
Development |
Innovative Medicines |
Research & Development |
17. September 2024 |
| Director Quantitative Safety Scientist |
Dublin (Novartis Corporate Center (NOCC)) |
Irland |
Development |
Innovative Medicines |
Research & Development |
17. September 2024 |
| Global Labelling Manager |
London (The Westworks) |
Vereinigtes Königreich |
Development |
Innovative Medicines |
Research & Development |
17. September 2024 |
| SSO Site Partnership Manager |
Guangzhou (Guangdong Province) |
China |
Development |
Innovative Medicines |
Research & Development |
17. September 2024 |
| GCP Inspection Project Manager |
London (The Westworks) |
Vereinigtes Königreich |
Development |
Innovative Medicines |
Quality |
16. Oktober 2024 |
| Senior Expert Science & Technology, Analytical Development |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
16. Oktober 2024 |
| RA Operational Excellence Junior Associate – MEA |
Dubai |
Vereinigte Arabische Emirate |
Development |
Innovative Medicines |
Research & Development |
16. Oktober 2024 |
| Country Patient Safety Head - France |
Paris Headquarter (Novartis Pharma S.A.S.) |
Frankreich |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Senior Expert Technical Development- Drug Product Project Lead |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Vendor Alliance Lead Associate Director (Remote) |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Global Program Safety Lead - Immunology |
Basel (City) |
Schweiz |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Global Program Safety Lead - Immunology |
London (The Westworks) |
Vereinigtes Königreich |
Development |
Sandoz |
Research & Development |
17. Oktober 2024 |
| Strategy Director, Clinical Development |
Basel (City) |
Schweiz |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Expert Science & Technology II- Analytical Research & Development |
Changshu (Jiangsu Province) |
China |
Development |
Innovative Medicines |
Research & Development |
18. September 2024 |
| Global Program Clinical Head: In-market Brands |
London (The Westworks) |
Vereinigtes Königreich |
Development |
Innovative Medicines |
Research & Development |
18. September 2024 |
| Senior Expert, Science & Technology - Potency |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
18. September 2024 |
| Executive Director, Global Operational Excellence |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
18. September 2024 |
| Senior Principal Statistical Programmer - Advanced Quantitative Sciences |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
19. September 2024 |
| Associate Director, Statistical Programming |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
19. September 2024 |
| Clinical Development Medical Director - Renal **80-100% |
Basel (City) |
Schweiz |
Development |
Innovative Medicines |
Research & Development |
20. September 2024 |
| Global Program Clinical Head - CRM |
Basel (City) |
Schweiz |
Development |
Innovative Medicines |
Research & Development |
20. September 2024 |
| Associate Director, Clinical QA |
East Hanover |
USA |
Development |
Innovative Medicines |
Quality |
24. September 2024 |
| Associate Director Strategy and Operations |
Hyderabad (Office) |
Indien |
Development |
Innovative Medicines |
Research & Development |
24. September 2024 |
| Technician, Science & Technology - Analytical Development |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
24. Oktober 2024 |
| Senior Global Labelling Coordinator |
London (The Westworks) |
Vereinigtes Königreich |
Development |
Innovative Medicines |
Research & Development |
25. Oktober 2024 |
| Global Labelling Manager |
Dublin (Novartis Corporate Center (NOCC)) |
Irland |
Development |
Innovative Medicines |
Research & Development |
25. Oktober 2024 |
| RA Head India |
Mumbai (Head Office) |
Indien |
Development |
Sandoz |
Research & Development |
25. Oktober 2024 |
| Analytical Expert – Trace Level Analytics (m/f/d) |
Basel (City) |
Schweiz |
Development |
Innovative Medicines |
Research & Development |
25. Oktober 2024 |
| Expert Science & Technology – Trace level analytics (e.g. nitrosamines, genotoxic impurities) |
Basel (City) |
Schweiz |
Development |
Innovative Medicines |
Research & Development |
25. Oktober 2024 |